Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person MicroRNA-340 (miR-340) plays a critical role in osteoclast d...
| Class:Id | Summation:9924925 |
| _displayName | MicroRNA-340 (miR-340) plays a critical role in osteoclast d... |
| _timestamp | 2024-10-29 11:59:44 |
| created | [InstanceEdit:9925315] Tiwari, Krishna, 2024-10-16 |
| literatureReference | [LiteratureReference:9925271] miRNA-340 inhibits osteoclast differentiation via repression of MITF [LiteratureReference:9925081] miR-340: A multifunctional role in human malignant diseases [LiteratureReference:9925239] Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer |
| modified | [InstanceEdit:9925426] Tiwari, Krishna, 2024-10-16 [InstanceEdit:9925973] Tiwari, Krishna, 2024-10-29 |
| text | MicroRNA-340 (miR-340) plays a critical role in osteoclast differentiation and tumor progression. It has been extensively studied for its expression and role in cell proliferation, metastasis and osteoporosis (Zhao et al., 2017, Huang et al., 2021). miR-340 binds to the 3’UTR of CD274 (PD-L1) mRNA and suppresses its translation (Dong et al., 2019). |
| (summation) | [Reaction:9925095] CD274 mRNA binds miR-340 RISC [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by MicroRNA-340 (miR-340) plays a critical role in osteoclast d... (9924925)